Houston Chronicle: Danaher's Spin Off: What Investors Need to Know About Fortive
MSN: Is Danaher’s Q3 beat enough to reignite long-term growth for DHR investors?
Is Danaher’s Q3 beat enough to reignite long-term growth for DHR investors?
Seeking Alpha: Danaher Vs. Agilent: Which Is The Better Option For Long-Term Investors
The Relative Strength (RS) Rating for DanaherDHR headed into a new percentile Tuesday, as it got a lift from 69 to 72. Please watch the video at Investors.com - Market Breadth: How This Indicator ...
Benzinga.com: ROSEN, LEADING INVESTOR COUNSEL, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important September 15 Deadline in Securities Class Action - DHR
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Danaher Corporation DHR between and , both dates inclusive (the "Class Period") ...
ROSEN, LEADING INVESTOR COUNSEL, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important September 15 Deadline in Securities Class Action - DHR
Oklahoma's News: Danaher to Webcast Bioprocessing Investor and Analyst Meeting at Cytiva
Bloomberg Law News: Danaher Settles Investor Suit Over Projections for $173 Million
Danaher Corp. has reached a nearly $173 million class settlement with investors who allege it misrepresented demand for its tests and vaccine equipment as the Covid-19 pandemic waned, according to a ...
Seeking Alpha on MSN: Danaher inks $173M deal to settle investor suit over post-pandemic forecast
Danaher Corporation (DHR) has agreed to pay $172.5M to settle a class action lawsuit filed by a group of investors who accused the company of misrepresenting demand for its test and vaccine equipment ...